Finally, BIRC3 is shown to be a key mediator of hypoxia-mediated survival adaptation of GBM to RT through inhibition of caspase activation, suggesting that agents that disable this apoptotic regulator could have activity against mesenchymal GBM, which has dismal prognosis. This evidence concerns the gene BIRC3 and glioblastoma.